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silybin is the major one), has received a tremendous attention over the last decade as an 79 herbal remedy for liver treatment over 30 years. In many cases, the antioxidant properties of 80 silymarin are considered to be responsible for its protective actions (Surai 2015) , through 81 alleviating oxidative stress and inflammatory response (Feng et al. 2016) . Silymarin is 82 commonly prescribed in cases of viral hepatitis or cirrhosis (Del Prete et al. 2012) because it 83 has hepatoprotective activity (Al-Sayed and Esmat 2016).
84
Lactulose modifies the bacterial profile in intestinal contents, increasing the lactobacilli and 85 bifidobacteria counts, up-regulating short-chain fatty acids production (Algieri et al. 2014) .
86
Lactulose used for the treatment of hepatic encephalopathy(HE) and is effective for primary 87 prevention of overt hepatic encephalopathy in patients with cirrhosis (Sharma et al. 2012 (Amin et al. 2012; Gu et al. 2011a; Gu et al. 2011b ) .
154
Collection of blood samples and liver tissues 155 At the end of the experiment, all rats were fasted for 12 h then 5-8 ml whole blood samples 156 were taken directly from the heart under ketamine 10% -xylazine 2% anesthesia. The blood 157 samples were centrifuged at 10000 rpm for 20 min for serum separation. All animals were 158 sacrificed and their liver dissected out. Right lobe of the liver was cut and fixed in 10% D r a f t 8 MDA measurement has been used frequently to measure lipid peroxidation. The lipid 174 peroxidation assay was performed by determining the MDA, which is the end product of lipid substance (TBARS) to produce a red colored complex that has a peak absorbance (A) at 535 177 nm. A mixture of trichloroacetic acid (TCA), TBA, and HCl were added to 1mL of serum, 178 and the mixture was heated for 45 min in a boiling water bath. After cooling and centrifuging 179 it at 1000 g for 10 min, the cleared supernatant absorbance was measured using SECOMAM histological parameters were done by Mann-Whitney U from two independent sample tests.
204
Significant differences were analyzed at P < 0.05.
206

Results
207
Mortalities and liver function
208
During the whole experimental period, there were minor rat deaths. A total of three rats died: 209 one rat died from the normal group; two rats died in making cirrhotic model. The mortality 210 rate was not more than 7.5% which makes the survival rate of the model 92.5%. (Table 1) .
211
Levels of serum ALT and AST were assayed as markers of liver injury. thioacetamide in TAA group serum ALT and AST levels was high and significant in AST comparing with 215 control group (P < 0.05), while treatment with treatments, decreased AST and ALT levels.
216
Silymarin administration decreased AST and significantly decreased ALT level compared with 217 a TAA group (P < 0.05). Lactulose and both silymarin and lactulose significantly decreased 218 liver enzymes (P < 0.01 and P < 0.05) as shown in (Figure 2 , A and B).
219
The plasma ALP level of the thioacetamide group increased significantly (P < 0.001) when 220 compared with the control group ( Figure 2C ). ALP levels was significantly decreased in SM, AST resume to the levels lower as that of control rats but ALP did not resume to the levels as 229 that of control rats. In SM + LAC group, recovery of liver dysfunction resume to the levels of 230 control rats in AST and lower of control rats in ALT but still ALP is higher than control group.
231
There was a significant increase (P < 0.05 and P < 0.01) in serum total bilirubin of lactulose 232 group (2 g/kg/day) when compared with control, TAA and SM groups. Therefore there are no 233 significant differences between TAA, SM and SM + LAC groups and the control group, as 234 shown in (Table 2) .
236
It seems that after 8 weeks liver dysfunction improved upon thioacetamide withdrawal and 237 liver ability to synthesize the albumin and other proteins resume to the levels as that of the 238 healthy rats so there are no significant differences between all groups and the control group, 239 except for SM+LAC which are significantly lower than TAA group as shown in (Table 2) 240 which it could be explained by albumin's long half-life.
241 Table 3 indicates the effect of silymarin and lactulose and their combination on the GGT 242 levels in the serum of control and experimental groups of rats. This marker enzyme is 243 significantly (P < 0.05) increased in TAA and SM + LAC animals when compared with After 18-weeks of thioacetamid administration and 8-weeks of treatment, the weight of rats in 254 the TAA group was non-significantly less than rats in control group (Table 3 ). The weight of 255 rats in LAC and SM+LAC groups non-significantly increased compared with control and 256
TAA groups. Weight of liver in LAC and SM + LAC groups were significantly higher than 257 liver weight in control group (P < 0.05).
258
The liver index used to assess liver damage. LIs of LAC and SM+LAC rats increased and 259 remained at significant higher levels to that of the control (P < 0.05), except for SM group 260 which wasn't remarkably higher than control group (Figure 4 ).
261
Liver index in the thioacetamide group increased compared with those of normal group,
262
while silymarin group was decreased compared with thioacetamide group but wasn't 263 significant. The results showed that hepatomegaly alleviated after the treatments (Figure 4 . area that extended into the surrounding liver lobules, this leads to criteria of hepatic cirrhosis.
280
In control group of rats we observed normal architecture of liver cells, containing uniform 281 granulated cytoplasm and small nuclei. Collagen fibers are thin and delicate ( Figure 5 ). form nodules and distort the architecture, and extensive fibrosis with broad septa was 308 observed ( Figure 5 ). These results definitely indicated that the rat model of liver cirrhosis was 309 successfully established. 
332
Thioacetamide had been confirmed to induce hepatic injury and trigger proliferation of liver,
333
noticeably increased the ratio of liver to overall body weight as presented in LI, which used 334 to scrutinize potential changes in the liver size, in comparison with control rats (Figure 4 ).
335
Thioacetamide, a potent centrilobular hepatotoxicant, undergoes a two-step bio activation 336 mediated by microsomal CYP2E1 to thioacetamide sulfoxide (TASO), and further to LAC and SM+LAC groups (Table 3) . Treatments decreased fibrosis scores in LAC and 365
SM+LAC groups compared to TAA group although it wasn't significant due to the short time liver enzymes activities in SM and LAC groups may be due to recovery, as decreasing serum 377 liver enzymes activities in hepatic injury occur with recovery, given that lactulose has a 378 function of reducing blood ammonia levels, and hydrogen produced by anaerobic organisms 379 was the key for its therapeutic effects. 
